Erste Asset Management Gmb H Pacira Bio Sciences, Inc. Transaction History

Erste Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 26, 2024	SELL	$27.7 - $35.48 $271,460 - $347,703	-9,800 Closed	0 $0
Q3 2022 Nov 26, 2024	BUY	$51.24 - $58.89 $502,152 - $577,122	9,800 New	9,800 $532 Million
Q2 2022 Nov 26, 2024	SELL	$51.49 - $81.64 $236,854 - $375,544	-4,600 Reduced 31.94%	9,800 $575 Million
Q1 2022 Nov 22, 2024	SELL	$60.03 - $76.49 $276,138 - $351,854	-4,600 Reduced 31.94%	9,800 $742 Million
Q4 2021 Nov 22, 2024	BUY	$47.97 - $62.21 $690,768 - $895,824	14,400 New	14,400 $896 Million
Q3 2020 Nov 22, 2024	BUY	$51.97 - $63.0 $748,368 - $907,200	14,400 New	14,400 $855 Million
Q4 2019 Nov 22, 2024	BUY	$36.31 - $46.83 $522,864 - $674,352	14,400 New	14,400 $642 Million
Q1 2019 Nov 22, 2024	BUY	$36.47 - $42.17 $525,168 - $607,248	14,400 New	14,400 $549 Million
Q4 2018 Nov 26, 2024	BUY	$41.31 - $52.16 $594,864 - $751,104	14,400 New	14,400 $599 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.